BERMAN DENNIS N — SEC Form 4 filings
SEC reporting owner CIK 1273858. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-31.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-07-18 to 2026-07-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | Director | 8 | — | — | 26 |
Form 4 filings — BERMAN DENNIS N
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-31 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Option exercise (M): 21,854 @ $1.26 · Option exercise (M): 21,854 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 108,176 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4/A | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 21,854 (derivative) @ $0 · Grant/award (A): 3,780 (derivative) @ $0 · Grant/award (A): 6,667 (derivative) @ $0 · Grant/award (A): 6,667 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 39,620 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Disposition to issuer (D): 21,854 (derivative) @ $0 · Grant/award (A): 21,854 (derivative) @ $0 · Disposition to issuer (D): 1,138 (derivative) @ $0 · Grant/award (A): 1,138 (derivative) @ $0 · Disposition to issuer (D): 3,780 (derivative) @ $0 · Grant/award (A): 3,780 (derivative) @ $0 · +6 more | EDGAR |
| 2025-01-07 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 344,452 (derivative) @ $0 · Grant/award (A): 172,191 (derivative) @ $0 · Grant/award (A): 316,647 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1273858 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →